FORA Capital’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History

FORA Capital’s Portfolio PAND Stock Details PAND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-870	Closed	-$52K	–	1255
2021 Q1	$52K	Buy	+870	New	+$31.5K	0.02%	541

FORA Capital's PAND Position: Q2 2021 in Review

FORA Capital sold out of Pandion Therapeutics Inc. Common Stock (PAND) in Q2 2021, closing a stake of 870 shares — an estimated $52K sold.

FORA Capital first reported a position in PAND in Q1 2021 and held it in 1 quarter. The position peaked at $52K in Q1 2021. 0 funds tracked by Wall St. Rank hold PAND as of Q2 2021.

FORA Capital reported no remaining Pandion Therapeutics Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
FORA Capital sold 870 Pandion Therapeutics Inc. Common Stock shares in Q2 2021, an estimated $52K.
FORA Capital first reported a position in Pandion Therapeutics Inc. Common Stock in Q1 2021 and held it in 1 quarter.
FORA Capital's Pandion Therapeutics Inc. Common Stock position peaked at $52K in Q1 2021.
0 funds tracked by Wall St. Rank held Pandion Therapeutics Inc. Common Stock as of Q2 2021.

Based on FORA Capital's 13F filing for Q2 2021, filed 16 Aug 2021.